For people living with diabetes, the daily burden of managing insulin doses could soon be significantly lighter, thanks to Beta Bionics. The Irvine, California-based company, which developed the iLet Bionic Pancreas, has raised $150.0M to advance its mission.
Beta Bionics' iLet system is an automated insulin delivery system featuring a fully closed loop algorithm that adapts to each person, determining and delivering every insulin dose. This innovative approach aims to bring greater ease, confidence, and freedom to those managing diabetes every day.
